Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
by on Thursday, January 26th, 2012 | No Comments
Conditions: Chemotherapy-induced Neutropenia; Breast Cancer
Interventions: Drug: LA-EP2006; Drug: Peg-Filgrastim
Sponsor: Sandoz
Recruiting – verified January 2012
Read the original here: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim